These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

209 related items for PubMed ID: 26345674

  • 21. Hyperkalemic distal renal tubular acidosis caused by immunosuppressant treatment with tacrolimus in a liver transplant patient: case report.
    Riveiro-Barciela M, Campos-Varela I, Tovar JL, Vargas V, Simón-Talero M, Ventura-Cots M, Crespo M, Bilbao I, Castells L.
    Transplant Proc; 2011 Dec; 43(10):4016-8. PubMed ID: 22172892
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Amelioration of hyperchloremic acidosis with furosemide therapy in patients with chronic renal insufficiency and type 4 renal tubular acidosis.
    Sebastian A, Schambelan M, Sutton JM.
    Am J Nephrol; 1984 Dec; 4(5):287-300. PubMed ID: 6524600
    [Abstract] [Full Text] [Related]

  • 29. Type 4 renal tubular acidosis in a patient with lupus nephritis.
    Akin D, Ozmen S.
    Iran J Kidney Dis; 2014 Jan; 8(1):73-5. PubMed ID: 24413726
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA, Houssiau F, Aranow C, D'Cruz DP, Askanase A, Roth DA, Zhong ZJ, Cooper S, Freimuth WW, Ginzler EM, BLISS-52 and -76 Study Groups.
    Lupus; 2013 Jan; 22(1):63-72. PubMed ID: 23263865
    [Abstract] [Full Text] [Related]

  • 32. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 33. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M, Saiz A, Fernández-Reyes MJ, Sánchez R, Zurita P, Urrego C.
    Nefrologia; 2011 Aug; 31(2):231-3. PubMed ID: 21461001
    [No Abstract] [Full Text] [Related]

  • 34. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide.
    Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D.
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):351-7. PubMed ID: 21080348
    [Abstract] [Full Text] [Related]

  • 35. Hyperkalemia due to hyporeninemic hypoaldosteronism with liver cirrhosis and hypertension.
    Kee CS, Choi JW, Chang DK, Ahn YH, Kim HJ.
    J Korean Med Sci; 1993 Dec; 8(6):464-70. PubMed ID: 8179835
    [Abstract] [Full Text] [Related]

  • 36. Hyperkalemia in acute glomerulonephritis due to transient hyporeninemic hypoaldosteronism.
    Don BR, Schambelan M.
    Kidney Int; 1990 Dec; 38(6):1159-63. PubMed ID: 2074657
    [Abstract] [Full Text] [Related]

  • 37. [Case of lupus nephritis and enteritis associated with bilateral hydronephrosis].
    Kato M, Nakazawa E, Akimoto T, Inoue M, Kanashiki E, Meguro D, Tozawa R, Muto S, Yumura W, Kusano E.
    Nihon Jinzo Gakkai Shi; 2009 Dec; 51(5):569-75. PubMed ID: 19715166
    [Abstract] [Full Text] [Related]

  • 38. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G, Danza A, Khamashta M.
    Med Clin (Barc); 2013 Dec 21; 141(12):533-42. PubMed ID: 23622892
    [Abstract] [Full Text] [Related]

  • 39. Acute onset of systemic lupus erythematosus with extensive gastrointestinal and genitourinary involvement.
    Tan TC, Wansaicheong GK, Thong BY.
    Lupus; 2012 Oct 21; 21(11):1240-3. PubMed ID: 22833436
    [Abstract] [Full Text] [Related]

  • 40. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, Garrido Ed Ede R, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2002 Aug 21; 46(8):2121-31. PubMed ID: 12209517
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.